There is evidence in the literature that combined ICI is more effective than anti-PD-1 monotherapy, also with regard to liver metastases.15 Recently, a comprehensive comparison of the available systemic therapies for metastatic uveal melanoma was carried out using a complex mathematical model. This evidence concerns the gene PDCD1 and uveal melanoma.